Literature DB >> 16313977

Cell-based models of sustained, interferon-sensitive hepatitis C virus genotype 1 replication.

Yoichi Hiasa1, Jason T Blackard, Wenyu Lin, Yoshitaka Kamegaya, Norio Horiike, Morikazu Onji, Emmett V Schmidt, Raymond T Chung.   

Abstract

We have previously reported hepatitis C virus (HCV) replication using a novel binary expression system in which mammalian cells were transfected with a T7 polymerase-driven full-length genotype 1a HCV cDNA plasmid (pT7-flHCV-Rz) and infected with vaccinia-T7 polymerase. We hypothesized that the use of replication-defective adenoviral vectors expressing T7 (Ad-T7pol) or cell lines stably transfected with T7 (Huh-T7) would alleviate cell toxicity and allow for more sustained HCV replication. CV-1, Huh7, and Huh-T7 cells were transfected with pT7-flHCV-Rz and treated with Ad-T7pol (CV-1 and Huh7 only). Protein and RNA were harvested from cells on days 1, 2, 3, 5, 7, and 9 post-infection. No cytotoxicity was observed at 9 days post-infection in any cell type. HCV positive- and negative-strand RNA expression were strongest during days 1-3 post-infection; however, HCV RNA remained detectable throughout the 9-day observation period. Furthermore, transfection with a replication-incompetent plasmid suggested that efficient HCV replication is dependent upon NS5B gene expression. Finally, after 1-2 days of IFN treatment, HCV positive-strand levels decreased significantly compared to HCV-infected but untreated samples (p<0.05). In conclusion, these refined binary systems offer more durable and authentic models for identification of host cellular processes critical to HCV replication and will permit longer-term analysis of virus-host interactions critical to HCV pathogenesis and the treatment of genotype 1 infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313977      PMCID: PMC2865175          DOI: 10.1016/j.jviromet.2005.10.014

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  33 in total

1.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

2.  A latent, nonpathogenic HSV-1-derived vector stably expresses beta-galactosidase in mouse neurons.

Authors:  A T Dobson; T P Margolis; F Sedarati; J G Stevens; L T Feldman
Journal:  Neuron       Date:  1990-09       Impact factor: 17.173

3.  Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase.

Authors:  J C Watson; H W Chang; B L Jacobs
Journal:  Virology       Date:  1991-11       Impact factor: 3.616

Review 4.  Adenovirus region E3 proteins that prevent cytolysis by cytotoxic T cells and tumor necrosis factor.

Authors:  W S Wold; L R Gooding
Journal:  Mol Biol Med       Date:  1989-10

5.  Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.

Authors:  Ana Maria Contreras; Yoichi Hiasa; Wenping He; Adam Terella; Emmett V Schmidt; Raymond T Chung
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

6.  The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase.

Authors:  H W Chang; J C Watson; B L Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

7.  Alpha interferon inhibits hepatitis C virus replication in primary human hepatocytes infected in vitro.

Authors:  Valérie Castet; Chantal Fournier; Alexandre Soulier; Rozenn Brillet; Joliette Coste; Dominique Larrey; Daniel Dhumeaux; Patrick Maurel; Jean-Michel Pawlotsky
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma.

Authors:  Yoichi Hiasa; Yoshitaka Kamegaya; Hideko Nuriya; Morikazu Onji; Michinori Kohara; Emmett V Schmidt; Raymond T Chung
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

9.  Strand specific quantitative real-time PCR to study replication of hepatitis C virus genome.

Authors:  Florence Komurian-Pradel; Magali Perret; Birgit Deiman; Mireille Sodoyer; Vincent Lotteau; Glaucia Paranhos-Baccalà; Patrice André
Journal:  J Virol Methods       Date:  2004-03-01       Impact factor: 2.014

10.  Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Authors:  Jens Bukh; Thomas Pietschmann; Volker Lohmann; Nicole Krieger; Kristina Faulk; Ronald E Engle; Sugantha Govindarajan; Max Shapiro; Marisa St Claire; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

View more
  7 in total

1.  Understanding the precise function of interferon regulatory factor 3 in hepatitis C virus replication will lead to a new strategy for therapy.

Authors:  Yoichi Hiasa; Morikazu Onji
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  High serum palmitic acid is associated with low antiviral effects of interferon-based therapy for hepatitis C virus.

Authors:  Teruki Miyake; Yoichi Hiasa; Masashi Hirooka; Yoshio Tokumoto; Takao Watanabe; Shinya Furukawa; Teruhisa Ueda; Shin Yamamoto; Teru Kumagi; Hiroaki Miyaoka; Masanori Abe; Bunzo Matsuura; Morikazu Onji
Journal:  Lipids       Date:  2012-09-16       Impact factor: 1.880

3.  Tumor necrosis factor α inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitis.

Authors:  Nanda Kumar N Shanmugam; Shiri Ellenbogen; Estela Trebicka; Lijian Wang; Subhankar Mukhopadhyay; Adam Lacy-Hulbert; Carey Ann Gallini; Wendy S Garrett; Bobby J Cherayil
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

4.  A preliminary analysis of hepatitis C virus in pancreatic islet cells.

Authors:  Jason T Blackard; Ling Kong; Angela Lombardi; Dirk Homann; Sara Salehi Hammerstad; Yaron Tomer
Journal:  Virol J       Date:  2017-12-20       Impact factor: 4.099

5.  HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.

Authors:  Giovanna Russelli; Paola Pizzillo; Gioacchin Iannolo; Floriana Barbera; Fabio Tuzzolino; Rosa Liotta; Mario Traina; Giovanni Vizzini; Bruno Gridelli; Ester Badami; Pier Giulio Conaldi
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

6.  Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis.

Authors:  Jason T Blackard; Ling Kong; Amanda K Huber; Yaron Tomer
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

7.  CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro.

Authors:  Jason T Blackard; Ling Kong; Susan D Rouster; Rebekah Karns; Paul S Horn; Shyam Kottilil; M Tarek Shata; Kenneth E Sherman
Journal:  PLoS One       Date:  2019-10-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.